<DOC>
	<DOCNO>NCT00213070</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy safety Miglitol patient Type2 Diabetes Mellitus treat insulin .</brief_summary>
	<brief_title>Double-Blind Trial Miglitol Type 2 Diabetic Patients With Insulin Treatment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Miglitol</mesh_term>
	<criteria>Type2 diabetes Criteria postprandial plasma glucose HbA1c meet Type1 diabetes Patients antidiabetic drug The exclusion criterion meet</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>alpha-glucosidase inhibitor , Insulin</keyword>
</DOC>